《科学》 第391卷 第6790期 · 2026年3月12日 · 中文解读
ARPA-H重金投入抗衰老药物研发
ARPA-H bets big to foster drugs that thwart aging · M. Leslie
约 9 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
美国卫生高级研究计划局(ARPA-H)上月发放高达1.44亿美元的合同,旨在为延长健康寿命的疗法审批铺平道路。
原文开头
Awards intended to “build the train tracks” for approval of therapies to extend healthy life MITCH LESLIE A ging is the unindicted coconspira- tor in many of the diseases that can make our later years miserable. But not a single treatment for aging has ever been rigorously tested and approved. By handing out up to $144 million in contracts last month, the Advanced Research Projects Agency for Health (ARPA-H), the U.S. government agency launched in 2022 to sponsor out-of-the- box biomedical science, aims to change that. …
摘自《科学》(Science)第391卷 第6790期 · 2026年3月12日,M. Leslie。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。

微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号